Viewing data from:

METHAZOLAMIDE

ANDA

METHAZOLAMIDE | A040001 | ANI PHARMACEUTICALS INC

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$1.52

per ea

Lowest NADAC/Unit

$0.7841

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
72603016701METHAZOLAMIDE 50 MG TABLET	$1.52	EA	Generic	—	2026-06-17
62559024101METHAZOLAMIDE 50 MG TABLET	$1.52	EA	Generic	—	2026-06-17
72603016601METHAZOLAMIDE 25 MG TABLET	$0.7841	EA	Generic	—	2026-06-17
62559024001METHAZOLAMIDE 25 MG TABLET	$0.7841	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$74.37

Highest Price

$148.74

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
51407-0026-01METHAZOLAMIDE 25MG TAB	$74.37	FSS	Golden State Medical Supply, Inc.	06/14/2028
51407-0027-01METHAZOLAMIDE 50MG TAB	$148.74	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain4 active DMFs3 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

FINE CHEMICALS CORP PTY LTDMETHAZOLAMIDE

DMF 79821989

DELMAR CHEMICALS INCMETHAZOLAMIDE

DMF 86761990

BIOPHORE INDIA PHARMACEUTICALS PVT LTDMETHAZOLAMIDE

DMF 323342017

MICRO LABS LTDMETHAZOLAMIDE USP

DMF 325142018

CHEMISCHE FABRIK WEYL GMBHInactiveMETHAZOLAMIDE

DMF 78561989

TCI AMERICAInactiveMETHAZOLAMIDE

DMF 78991989

CHONGQING NO. 5 PHARM. FACTORYInactiveMETHAZOLAMIDE

DMF 99351992

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 25MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jun 30, 1993

No patent or exclusivity listings for this strength.

#002 — 50MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jun 30, 1993